Li Meng, Xin Yongjie, Fu Sirui, Liu Zaiyi, Li Yong, Hu Baoshan, Chen Shuting, Liang Changhong, Lu Ligong
From the Southern Medical University, Guangzhou, China (ML, SC); Department of Radiology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China (ML, ZL, SC, CL); and Department of Interventional Radiology, Guangdong Provincial Cardiovascular Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China (YX, SF, YL, BH, LL).
Medicine (Baltimore). 2016 Jan;95(2):e2458. doi: 10.1097/MD.0000000000002458.
Corona enhancement and mosaic architecture are 2 radiologic features of hepatocellular carcinoma (HCC). However, neither their prognostic values nor their impacts on the selection of liver resection (LR) versus transcatheter arterial chemoembolization (TACE) as treatment modalities have been established.We retrospectively analyzed 275 patients with a single HCC lesion >5 cm without extrahepatic metastasis treated with LR or TACE. In LR patients, the overall survival (OS) and time to progression (TTP) were compared between corona enhancement negative (corona-) versus positive (corona+) and mosaic architecture negative (mosaic-) versus positive (mosaic+) patients. Furthermore, by the combination of corona and mosaic, LR patients were divided into negative for both corona and mosaic patterns (LR-/-), positive for only 1 feature (LR+/-), and positive for both (LR+/+); their OS and TTP were compared to those of the TACE group. Cox regression was performed to identify independent factors for OS.In the survival plots for LR, corona- had better OS and TTP than corona+, and mosaic- had better OS than mosaic+. There was no significant difference in TTP between the subgroups. On Cox regression analysis, corona enhancement, but not mosaic architecture, was a significant factor for OS, whereas neither were a significant factor for TTP. In TACE patients, neither corona nor mosaic patterns had significant correlations with OS or TTP. In the whole population, LR-/ and LR+/- subgroups had similar OS, which was better than the LR+/+ and TACE groups. Moreover, LR-/- and LR+/- patients had better TTP than TACE patients, but there were no differences between the LR-/- versus LR+/-, LR-/ versus LR+/+, LR+/- versus LR+/+, and LR+/+ versus TACE groups. On Cox regression analysis, the presence of corona/mosaic patterns was an independent prognostic factor for OS.Our results showed that, for patients with a single HCC >5 cm without extrahepatic metastasis, corona and mosaic patterns are indicators of limited LR efficacy. When both of the features are present, TACE can be used instead of LR with no negative influence on survival.
晕环强化和镶嵌结构是肝细胞癌(HCC)的两种放射学特征。然而,它们的预后价值以及对肝切除术(LR)与经动脉化疗栓塞术(TACE)作为治疗方式选择的影响尚未明确。我们回顾性分析了275例单个HCC病灶>5 cm且无肝外转移的患者,这些患者接受了LR或TACE治疗。在LR患者中,比较了晕环强化阴性(晕环-)与阳性(晕环+)以及镶嵌结构阴性(镶嵌-)与阳性(镶嵌+)患者的总生存期(OS)和疾病进展时间(TTP)。此外,根据晕环和镶嵌的组合,将LR患者分为晕环和镶嵌模式均为阴性(LR-/-)、仅1种特征为阳性(LR+/-)以及两者均为阳性(LR+/+);将他们的OS和TTP与TACE组进行比较。进行Cox回归以确定OS的独立因素。
在LR的生存曲线中,晕环-的OS和TTP优于晕环+,镶嵌-的OS优于镶嵌+。各亚组之间的TTP无显著差异。在Cox回归分析中,晕环强化而非镶嵌结构是OS的显著因素,而两者均不是TTP的显著因素。在TACE患者中,晕环和镶嵌模式与OS或TTP均无显著相关性。在整个研究人群中,LR-/-和LR+/-亚组的OS相似,均优于LR+/+和TACE组。此外,LR-/-和LR+/-患者的TTP优于TACE患者,但LR-/-与LR+/ -、LR-/-与LR+/ +、LR+/-与LR+/ +以及LR+/ +与TACE组之间无差异。在Cox回归分析中,晕环/镶嵌模式的存在是OS的独立预后因素。
我们的结果表明,对于单个HCC>5 cm且无肝外转移的患者,晕环和镶嵌模式是LR疗效有限的指标。当两种特征均存在时,可使用TACE替代LR,且对生存无负面影响。